Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC LSP-249 | 1801253-04-2 | 99.1% | 431.92 | 50 MG
Supplier: Medchemexpress LLC HY12637850MG
LSP-249 is a plasma kallikrein inhibitor currently under investigation for its potential use in treating angioedema. This compound was extracted from patent WO2016011209A1 and has demonstrated an EC50 less than 100 nM in cell studies. It is intended for research purposes only and not sold to patients.
- Plasma kallikrein inhibitor
- Under study for angioedema
- EC50 less than 100 nM in cell
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?